Eli Lilly and Company today announced that data from studies of imlunestrant, an investigational oral selective estrogen receptor degrader (SERD), olomorasib, an investigational KRAS G12C inhibitor, ...

EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 ...

The global market for peptide-based cancer therapies is rapidly expanding, offering new therapeutic and diagnostic opportunities. Peptides, known for their high specificity and minimized toxicity, ...

RC Mowers, a leading manufacturer of robotic and autonomous mowers, announced today that it has hired a new chief financial officer, along with key additions across its sales, engineering and human ...

Genmab A/S (Nasdaq: GMAB) announced today that it will present new research from its comprehensive development program evaluating its late-stage portfolio at the 2025 American Society of Clinical ...

A patient with relapsed follicular lymphoma achieved complete remission one month after PMB-CT01 treatment in the phase 1 PMB-102 trial.

BioSpace examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made ...

LTRN READ THE FULL LTRN RESEARCH REPORT Lantern Pharma, Inc (NASDAQ:LTRN) reported first quarter 2025 results. Since the full ...

Explore plasma proteomics innovations tackling the dynamic range challenge, revealing biomarkers and advancing personalized ...

A research team led by Prof. Li Yunhai from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese Academy ...

BeiGene , Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Lt ...